SCHEMBL21045478

SCHEMBL21045478

Cc1cc2ncc(C(=O)NCCCc3ccc(-c4ccc5[nH]ncc5c4C)cc3)cn2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
KIT P10721 2/20 0.38
PDK1 Q15118 2/20 0.37
PPARG P37231 1/20 0.36
METAP2 P50579 2/20 0.36
DPP4 P27487 2/20 0.35
DPP8 Q6V1X1 2/20 0.35
DPP9 Q86TI2 2/20 0.35
FAP Q12884 1/20 0.35
KDM4E B2RXH2 3/20 0.34
POLB P06746 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
APOBEC3A P31941 1/20 0.34
HSD17B10 Q99714 1/20 0.34
WNT1 P04628 1/20 0.34
DYRK1A Q13627 1/20 0.34
NAMPT P43490 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045266 0.84 KDM4E (0.49) PDK1PPARGMETAP2KDM4EPOLB
SCHEMBL21045541 0.81 PDK1 (0.40) PDK1PPARGMETAP2ROCK2ROCK1
SCHEMBL29411428 0.81 LMNA (0.43) LMNAPPARGKDM4EPOLBRAB9A
SCHEMBL21045521 0.81 LMNA (0.43) LMNAPPARGKDM4EPOLBRAB9A
SCHEMBL21045313 0.76 FLT3 (0.47) ROCK1
SCHEMBL21045128 0.76 NPC1 (0.39) PDK1METAP2RAB9ASMN1; SMN2ROCK2
SCHEMBL21045169 0.76 LMNA (0.49) LMNAPDK1METAP2ROCK2ROCK1
SCHEMBL21045108 0.76 FYN (0.40) LMNAROCK2ROCK1
SCHEMBL29411420 0.76 FYN (0.40) LMNAROCK2ROCK1
SCHEMBL21045413 0.75 PDK1 (0.43) KITPDK1PPARGSMN1; SMN2ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed
US-11040945-B2 Tubulin inhibitors LIN BIOSCIENCE PTY LTD. 2021-06-22 US disclosed
US-11040945-B2 Tubulin inhibitors LIN BIOSCIENCE PTY LTD. 2021-06-22 US disclosed
WO-2019113242-A1 TUBULIN INHIBITORS Lin BioScience, LLC (US) 2019-06-13 WO disclosed
US-20190169127-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2019-06-06 US disclosed
US-20190169127-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB LMNA 2547/4885KIT 4738/4885PDK1 2961/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB LMNA 2547/4885KIT 4738/4885PDK1 2961/4885
US-11040945-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB LMNA 2547/4885KIT 4738/4885PDK1 2961/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB LMNA 2547/4885KIT 4738/4885PDK1 2961/4885
US-20190169127-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB LMNA 2547/4885KIT 4738/4885PDK1 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.